Log In
Print
BCIQ
Print
Print this Print this
 

Rilotumumab (AMG 102)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHuman mAb against human hepatocyte growth factor/scatter factor (HGF/SF)
Molecular Target Hepatocyte growth factor/scatter factor (HGF/SF)
Mechanism of ActionAntibody
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today